The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Kindred Healthcare's revenues will grow 3.6% and EPS will grow 63.0%.
The average estimate for revenue is $1.58 billion. On the bottom line, the average EPS estimate is $0.44.
Last quarter, Kindred Healthcare tallied revenue of $1.53 billion. GAAP reported sales were 0.8% higher than the prior-year quarter's $1.51 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.21. GAAP EPS of $0.14 for Q3 were 367% higher than the prior-year quarter's $0.03 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 33.2%, 30 basis points worse than the prior-year quarter. Operating margin was 2.8%, 80 basis points worse than the prior-year quarter. Net margin was 0.5%, 40 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $6.22 billion. The average EPS estimate is $1.44.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 135 members out of 145 rating the stock outperform, and 10 members rating it underperform. Among 49 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 47 give Kindred Healthcare a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Kindred Healthcare is hold, with an average price target of $12.00.
Is Kindred Healthcare the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Kindred Healthcare to My Watchlist.